The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery

The Port Delivery System with ranibizumab (PDS) is an innovative intraocular drug delivery system designed for the continuous delivery of ranibizumab into the vitreous for 6 months and beyond. The PDS includes an ocular implant, a customized formulation of ranibizumab, and four dedicated ancillary d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranade, Shrirang V., Wieland, Mark R., Tam, Tammy, Rea, Jennifer C., Horvath, Judit, Hieb, Aaron R., Jia, Weitao, Grace, Lori, Barteselli, Giulio, Stewart, Jay M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067954/
https://www.ncbi.nlm.nih.gov/pubmed/35499315
http://dx.doi.org/10.1080/10717544.2022.2069301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067954/
https://www.ncbi.nlm.nih.gov/pubmed/35499315
http://dx.doi.org/10.1080/10717544.2022.2069301

Ejemplares similares